Corebridge Financial Inc. Sells 843 Shares of Chemed Co. (NYSE:CHE)

Corebridge Financial Inc. lessened its holdings in shares of Chemed Co. (NYSE:CHE) by 4.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,971 shares of the company’s stock after selling 843 shares during the quarter. Corebridge Financial Inc.’s holdings in Chemed were worth $8,991,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. CIBC Asset Management Inc boosted its stake in shares of Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock worth $242,000 after acquiring an additional 22 shares during the period. CBIZ Investment Advisory Services LLC lifted its holdings in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock valued at $30,000 after purchasing an additional 22 shares during the last quarter. EP Wealth Advisors LLC boosted its position in Chemed by 1.9% during the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after purchasing an additional 25 shares during the period. Independent Advisor Alliance increased its holdings in shares of Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock valued at $1,207,000 after purchasing an additional 25 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Chemed by 7.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company’s stock valued at $264,000 after purchasing an additional 33 shares during the period. Institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

CHE has been the subject of several research analyst reports. Royal Bank of Canada lifted their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.

Insider Buying and Selling

In related news, VP Brian C. Judkins purchased 145 shares of the business’s stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is owned by insiders.

Chemed Price Performance

Shares of NYSE CHE opened at $612.09 on Friday. The firm has a market cap of $8.96 billion, a price-to-earnings ratio of 30.93, a P/E/G ratio of 2.15 and a beta of 0.43. The stock’s fifty day moving average price is $573.14 and its two-hundred day moving average price is $566.47. Chemed Co. has a one year low of $512.12 and a one year high of $646.71.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed’s dividend payout ratio (DPR) is presently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.